ABOUT US
CONTACT US
FAQ
PRIVACY POLICY
REFUND AND CANCELLATION
BLOGS
COMPANIES
REPORTS
0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative
0
U.S. (TOLL FREE)
+1 (315) 215-3225
Global Arginase Deficiency Drugs Market Insights, Forecast to 2030
Published Date: December 2024
|
Report Code: QYRE-Auto-14W1127
Home | Market Reports | Health| Nutrition| Vitamins & Supplements
Global Arginase Deficiency Drugs Market Insights Forecast to 2028
BUY CHAPTERS

Global Arginase Deficiency Drugs Market Insights, Forecast to 2030

Code: QYRE-Auto-14W1127
Report
December 2024
Pages:73
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES
FEATURED COMPANIES
Helsinn Healthcare
Novartis Pharmaceuticals
Horizo​​n Pharma
Medicis Pharmaceutical

Arginase Deficiency Drugs Market Size

The global Arginase Deficiency Drugs market is projected to grow from US$ 107 million in 2024 to US$ 137 million by 2030, at a Compound Annual Growth Rate (CAGR) of 4.2% during the forecast period.

Arginase Deficiency Drugs Market

Arginase Deficiency Drugs Market

Argininemia, also called arginase deficiency, is an autosomal recessive urea cycle disorder where adeficiency of the enzyme arginase causes a buildup of arginine and ammonia in the blood.
Market Analysis and Insights: Global Arginase Deficiency Drugs Market
The Arginase deficiency drugs market is driven by the growing awareness and diagnosis of this rare genetic disorder. As understanding of the disease improves, more patients are being identified and seeking treatment options. The development of targeted therapies to address the underlying metabolic abnormalities associated with Arginase deficiency has also contributed to market growth. Additionally, government initiatives and orphan drug designations have facilitated research and development in this area. However, the market faces challenges like limited patient populations, high treatment costs, and the need for specialized medical expertise for diagnosis and management. Overcoming these challenges through increased awareness, early diagnosis, and affordable access to therapies will be essential for the sustained growth of the Arginase deficiency drugs market.
Report Covers:
This report presents an overview of global market for Arginase Deficiency Drugs market size. Analyses of the global market trends, with historic market revenue data for 2019 - 2023, estimates for 2024, and projections of CAGR through 2030.
This report researches the key producers of Arginase Deficiency Drugs, also provides the revenue of main regions and countries. Highlights of the upcoming market potential for Arginase Deficiency Drugs, and key regions/countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.
This report focuses on the Arginase Deficiency Drugs revenue, market share and industry ranking of main companies, data from 2019 to 2024. Identification of the major stakeholders in the global Arginase Deficiency Drugs market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.
This report analyzes the segments data by Type and by Application, revenue, and growth rate, from 2019 to 2030. Evaluation and forecast the market size for Arginase Deficiency Drugs revenue, projected growth trends, production technology, application and end-user industry.
Market Segmentation

Scope of Arginase Deficiency Drugs Market Report

Report Metric Details
Report Name Arginase Deficiency Drugs Market
Accounted market size in 2024 US$ 107 in million
Forecasted market size in 2030 US$ 137 million
CAGR 4.2
Base Year 2024
Forecasted years 2025 - 2030
Segment by Type
Segment by Application
By Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia) Rest of Europe
  • Nordic Countries
  • Asia-Pacific (China, Japan, South Korea)
  • Southeast Asia (India, Australia)
  • Rest of Asia
  • Latin America (Mexico, Brazil)
  • Rest of Latin America
  • Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company Helsinn Healthcare, Novartis Pharmaceuticals, Horizo​​n Pharma, Medicis Pharmaceutical
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

  • Chapter 1: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
  • Chapter 2: Revenue of Arginase Deficiency Drugs in global and regional level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world. This section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
  • Chapter 3: Detailed analysis of Arginase Deficiency Drugs companies’ competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
  • Chapter 4: Provides the analysis of various market segments by Type, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different market segments.
  • Chapter 5: Provides the analysis of various market segments by Application, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
  • Chapter 6: North America (US & Canada) by Type, by Application and by country, revenue for each segment.
  • Chapter 7: Europe by Type, by Application and by country, revenue for each segment.
  • Chapter 8: China by Type, and by Application, revenue for each segment.
  • Chapter 9: Asia (excluding China) by Type, by Application and by region, revenue for each segment.
  • Chapter 10: Middle East, Africa, and Latin America by Type, by Application and by country, revenue for each segment.
  • Chapter 11: Provides profiles of key companies, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Arginase Deficiency Drugs revenue, gross margin, and recent development, etc.
  • Chapter 12: Analyst's Viewpoints/Conclusions

FAQ for this report

How fast is Arginase Deficiency Drugs Market growing?

Ans: The Arginase Deficiency Drugs Market witnessing a CAGR of 4.2 during the forecast period 2025-2030.

What is the Arginase Deficiency Drugs Market size in 2030?

Ans: The Arginase Deficiency Drugs Market size in 2030 will be US$ 137 million.

Who are the main players in the Arginase Deficiency Drugs Market report?

Ans: The main players in the Arginase Deficiency Drugs Market are Helsinn Healthcare, Novartis Pharmaceuticals, Horizo​​n Pharma, Medicis Pharmaceutical

What are the Application segmentation covered in the Arginase Deficiency Drugs Market report?

Ans: The Applications covered in the Arginase Deficiency Drugs Market report are Hospital, Drugs Stores, Other

What are the Type segmentation covered in the Arginase Deficiency Drugs Market report?

Ans: The Types covered in the Arginase Deficiency Drugs Market report are Oral, Injection

Recommended Reports

Metabolic Disorder Treatments

Rare Genetic Disorders

Amino Acid and Protein Markets

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Arginase Deficiency Drugs Market Size Growth Rate by Type, 2019 VS 2023 VS 2030
1.2.2 Oral
1.2.3 Injection
1.3 Market by Application
1.3.1 Global Arginase Deficiency Drugs Market Size Growth Rate by Application, 2019 VS 2023 VS 2030
1.3.2 Hospital
1.3.3 Drugs Stores
1.3.4 Other
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global Arginase Deficiency Drugs Market Perspective (2019-2030)
2.2 Global Arginase Deficiency Drugs Growth Trends by Region
2.2.1 Arginase Deficiency Drugs Market Size by Region: 2019 VS 2023 VS 2030
2.2.2 Arginase Deficiency Drugs Historic Market Size by Region (2019-2024)
2.2.3 Arginase Deficiency Drugs Forecasted Market Size by Region (2025-2030)
2.3 Arginase Deficiency Drugs Market Dynamics
2.3.1 Arginase Deficiency Drugs Industry Trends
2.3.2 Arginase Deficiency Drugs Market Drivers
2.3.3 Arginase Deficiency Drugs Market Challenges
2.3.4 Arginase Deficiency Drugs Market Restraints
3 Competition Landscape by Key Players
3.1 Global Revenue Arginase Deficiency Drugs by Players
3.1.1 Global Arginase Deficiency Drugs Revenue by Players (2019-2024)
3.1.2 Global Arginase Deficiency Drugs Revenue Market Share by Players (2019-2024)
3.2 Global Arginase Deficiency Drugs Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Global Key Players of Arginase Deficiency Drugs, Ranking by Revenue, 2022 VS 2023 VS 2024
3.4 Global Arginase Deficiency Drugs Market Concentration Ratio
3.4.1 Global Arginase Deficiency Drugs Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Arginase Deficiency Drugs Revenue in 2023
3.5 Global Key Players of Arginase Deficiency Drugs Head office and Area Served
3.6 Global Key Players of Arginase Deficiency Drugs, Product and Application
3.7 Global Key Players of Arginase Deficiency Drugs, Date of Enter into This Industry
3.8 Mergers & Acquisitions, Expansion Plans
4 Arginase Deficiency Drugs Breakdown Data by Type
4.1 Global Arginase Deficiency Drugs Historic Market Size by Type (2019-2024)
4.2 Global Arginase Deficiency Drugs Forecasted Market Size by Type (2025-2030)
5 Arginase Deficiency Drugs Breakdown Data by Application
5.1 Global Arginase Deficiency Drugs Historic Market Size by Application (2019-2024)
5.2 Global Arginase Deficiency Drugs Forecasted Market Size by Application (2025-2030)
6 North America
6.1 North America Arginase Deficiency Drugs Market Size (2019-2030)
6.2 North America Arginase Deficiency Drugs Market Size by Type
6.2.1 North America Arginase Deficiency Drugs Market Size by Type (2019-2024)
6.2.2 North America Arginase Deficiency Drugs Market Size by Type (2025-2030)
6.2.3 North America Arginase Deficiency Drugs Market Share by Type (2019-2030)
6.3 North America Arginase Deficiency Drugs Market Size by Application
6.3.1 North America Arginase Deficiency Drugs Market Size by Application (2019-2024)
6.3.2 North America Arginase Deficiency Drugs Market Size by Application (2025-2030)
6.3.3 North America Arginase Deficiency Drugs Market Share by Application (2019-2030)
6.4 North America Arginase Deficiency Drugs Market Size by Country
6.4.1 North America Arginase Deficiency Drugs Market Size by Country: 2019 VS 2023 VS 2030
6.4.2 North America Arginase Deficiency Drugs Market Size by Country (2019-2024)
6.4.3 North America Arginase Deficiency Drugs Market Size by Country (2025-2030)
6.4.4 U.S.
6.4.5 Canada
7 Europe
7.1 Europe Arginase Deficiency Drugs Market Size (2019-2030)
7.2 Europe Arginase Deficiency Drugs Market Size by Type
7.2.1 Europe Arginase Deficiency Drugs Market Size by Type (2019-2024)
7.2.2 Europe Arginase Deficiency Drugs Market Size by Type (2025-2030)
7.2.3 Europe Arginase Deficiency Drugs Market Share by Type (2019-2030)
7.3 Europe Arginase Deficiency Drugs Market Size by Application
7.3.1 Europe Arginase Deficiency Drugs Market Size by Application (2019-2024)
7.3.2 Europe Arginase Deficiency Drugs Market Size by Application (2025-2030)
7.3.3 Europe Arginase Deficiency Drugs Market Share by Application (2019-2030)
7.4 Europe Arginase Deficiency Drugs Market Size by Country
7.4.1 Europe Arginase Deficiency Drugs Market Size by Country: 2019 VS 2023 VS 2030
7.4.2 Europe Arginase Deficiency Drugs Market Size by Country (2019-2024)
7.4.3 Europe Arginase Deficiency Drugs Market Size by Country (2025-2030)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic Countries
8 China
8.1 China Arginase Deficiency Drugs Market Size (2019-2030)
8.2 China Arginase Deficiency Drugs Market Size by Type
8.2.1 China Arginase Deficiency Drugs Market Size by Type (2019-2024)
8.2.2 China Arginase Deficiency Drugs Market Size by Type (2025-2030)
8.2.3 China Arginase Deficiency Drugs Market Share by Type (2019-2030)
8.3 China Arginase Deficiency Drugs Market Size by Application
8.3.1 China Arginase Deficiency Drugs Market Size by Application (2019-2024)
8.3.2 China Arginase Deficiency Drugs Market Size by Application (2025-2030)
8.3.3 China Arginase Deficiency Drugs Market Share by Application (2019-2030)
9 Asia (excluding China)
9.1 Asia Arginase Deficiency Drugs Market Size (2019-2030)
9.2 Asia Arginase Deficiency Drugs Market Size by Type
9.2.1 Asia Arginase Deficiency Drugs Market Size by Type (2019-2024)
9.2.2 Asia Arginase Deficiency Drugs Market Size by Type (2025-2030)
9.2.3 Asia Arginase Deficiency Drugs Market Share by Type (2019-2030)
9.3 Asia Arginase Deficiency Drugs Market Size by Application
9.3.1 Asia Arginase Deficiency Drugs Market Size by Application (2019-2024)
9.3.2 Asia Arginase Deficiency Drugs Market Size by Application (2025-2030)
9.3.3 Asia Arginase Deficiency Drugs Market Share by Application (2019-2030)
9.4 Asia Arginase Deficiency Drugs Market Size by Region
9.4.1 Asia Arginase Deficiency Drugs Market Size by Region: 2019 VS 2023 VS 2030
9.4.2 Asia Arginase Deficiency Drugs Market Size by Region (2019-2024)
9.4.3 Asia Arginase Deficiency Drugs Market Size by Region (2025-2030)
9.4.4 Japan
9.4.5 South Korea
9.4.6 China Taiwan
9.4.7 Southeast Asia
9.4.8 India
9.4.9 Australia
10 Middle East, Africa, and Latin America
10.1 Middle East, Africa, and Latin America Arginase Deficiency Drugs Market Size (2019-2030)
10.2 Middle East, Africa, and Latin America Arginase Deficiency Drugs Market Size by Type
10.2.1 Middle East, Africa, and Latin America Arginase Deficiency Drugs Market Size by Type (2019-2024)
10.2.2 Middle East, Africa, and Latin America Arginase Deficiency Drugs Market Size by Type (2025-2030)
10.2.3 Middle East, Africa, and Latin America Arginase Deficiency Drugs Market Share by Type (2019-2030)
10.3 Middle East, Africa, and Latin America Arginase Deficiency Drugs Market Size by Application
10.3.1 Middle East, Africa, and Latin America Arginase Deficiency Drugs Market Size by Application (2019-2024)
10.3.2 Middle East, Africa, and Latin America Arginase Deficiency Drugs Market Size by Application (2025-2030)
10.3.3 Middle East, Africa, and Latin America Arginase Deficiency Drugs Market Share by Application (2019-2030)
10.4 Middle East, Africa, and Latin America Arginase Deficiency Drugs Market Size by Country
10.4.1 Middle East, Africa, and Latin America Arginase Deficiency Drugs Market Size by Country: 2019 VS 2023 VS 2030
10.4.2 Middle East, Africa, and Latin America Arginase Deficiency Drugs Market Size by Country (2019-2024)
10.4.3 Middle East, Africa, and Latin America Arginase Deficiency Drugs Market Size by Country (2025-2030)
10.4.4 Brazil
10.4.5 Mexico
10.4.6 Turkey
10.4.7 Saudi Arabia
10.4.8 Israel
10.4.9 GCC Countries
11 Key Players Profiles
11.1 Helsinn Healthcare
11.1.1 Helsinn Healthcare Company Details
11.1.2 Helsinn Healthcare Business Overview
11.1.3 Helsinn Healthcare Arginase Deficiency Drugs Introduction
11.1.4 Helsinn Healthcare Revenue in Arginase Deficiency Drugs Business (2019-2024)
11.1.5 Helsinn Healthcare Recent Developments
11.2 Novartis Pharmaceuticals
11.2.1 Novartis Pharmaceuticals Company Details
11.2.2 Novartis Pharmaceuticals Business Overview
11.2.3 Novartis Pharmaceuticals Arginase Deficiency Drugs Introduction
11.2.4 Novartis Pharmaceuticals Revenue in Arginase Deficiency Drugs Business (2019-2024)
11.2.5 Novartis Pharmaceuticals Recent Developments
11.3 Horizo​​n Pharma
11.3.1 Horizo​​n Pharma Company Details
11.3.2 Horizo​​n Pharma Business Overview
11.3.3 Horizo​​n Pharma Arginase Deficiency Drugs Introduction
11.3.4 Horizo​​n Pharma Revenue in Arginase Deficiency Drugs Business (2019-2024)
11.3.5 Horizo​​n Pharma Recent Developments
11.4 Medicis Pharmaceutical
11.4.1 Medicis Pharmaceutical Company Details
11.4.2 Medicis Pharmaceutical Business Overview
11.4.3 Medicis Pharmaceutical Arginase Deficiency Drugs Introduction
11.4.4 Medicis Pharmaceutical Revenue in Arginase Deficiency Drugs Business (2019-2024)
11.4.5 Medicis Pharmaceutical Recent Developments
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
FEATURED COMPANIES
Helsinn Healthcare
Novartis Pharmaceuticals
Horizo​​n Pharma
Medicis Pharmaceutical
List of Tables
    Table 1. Global Arginase Deficiency Drugs Market Size Growth Rate by Type (US$ Million), 2019 VS 2023 VS 2030
    Table 2. Key Players of Oral
    Table 3. Key Players of Injection
    Table 4. Global Arginase Deficiency Drugs Market Size Growth Rate by Application (US$ Million), 2019 VS 2023 VS 2030
    Table 5. Global Arginase Deficiency Drugs Market Size Growth Rate (CAGR) by Region (US$ Million): 2019 VS 2023 VS 2030
    Table 6. Global Arginase Deficiency Drugs Market Size by Region (2019-2024) & (US$ Million)
    Table 7. Global Arginase Deficiency Drugs Market Share by Region (2019-2024)
    Table 8. Global Arginase Deficiency Drugs Forecasted Market Size by Region (2025-2030) & (US$ Million)
    Table 9. Global Arginase Deficiency Drugs Market Share by Region (2025-2030)
    Table 10. Arginase Deficiency Drugs Market Trends
    Table 11. Arginase Deficiency Drugs Market Drivers
    Table 12. Arginase Deficiency Drugs Market Challenges
    Table 13. Arginase Deficiency Drugs Market Restraints
    Table 14. Global Arginase Deficiency Drugs Revenue by Players (2019-2024) & (US$ Million)
    Table 15. Global Arginase Deficiency Drugs Revenue Share by Players (2019-2024)
    Table 16. Global Top Arginase Deficiency Drugs by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Arginase Deficiency Drugs as of 2023)
    Table 17. Global Arginase Deficiency Drugs Industry Ranking 2022 VS 2023 VS 2024
    Table 18. Global 5 Largest Players Market Share by Arginase Deficiency Drugs Revenue (CR5 and HHI) & (2019-2024)
    Table 19. Global Key Players of Arginase Deficiency Drugs, Headquarters and Area Served
    Table 20. Global Key Players of Arginase Deficiency Drugs, Product and Application
    Table 21. Global Key Players of Arginase Deficiency Drugs, Product and Application
    Table 22. Mergers & Acquisitions, Expansion Plans
    Table 23. Global Arginase Deficiency Drugs Market Size by Type (2019-2024) & (US$ Million)
    Table 24. Global Arginase Deficiency Drugs Revenue Market Share by Type (2019-2024)
    Table 25. Global Arginase Deficiency Drugs Forecasted Market Size by Type (2025-2030) & (US$ Million)
    Table 26. Global Arginase Deficiency Drugs Revenue Market Share by Type (2025-2030)
    Table 27. Global Arginase Deficiency Drugs Market Size by Application (2019-2024) & (US$ Million)
    Table 28. Global Arginase Deficiency Drugs Revenue Share by Application (2019-2024)
    Table 29. Global Arginase Deficiency Drugs Forecasted Market Size by Application (2025-2030) & (US$ Million)
    Table 30. Global Arginase Deficiency Drugs Revenue Share by Application (2025-2030)
    Table 31. North America Arginase Deficiency Drugs Market Size by Type (2019-2024) & (US$ Million)
    Table 32. North America Arginase Deficiency Drugs Market Size by Type (2025-2030) & (US$ Million)
    Table 33. North America Arginase Deficiency Drugs Market Size by Application (2019-2024) & (US$ Million)
    Table 34. North America Arginase Deficiency Drugs Market Size by Application (2025-2030) & (US$ Million)
    Table 35. North America Arginase Deficiency Drugs Growth Rate (CAGR) by Country (US$ Million): 2019 VS 2023 VS 2030
    Table 36. North America Arginase Deficiency Drugs Market Size by Country (2019-2024) & (US$ Million)
    Table 37. North America Arginase Deficiency Drugs Market Size by Country (2025-2030) & (US$ Million)
    Table 38. Europe Arginase Deficiency Drugs Market Size by Type (2019-2024) & (US$ Million)
    Table 39. Europe Arginase Deficiency Drugs Market Size by Type (2025-2030) & (US$ Million)
    Table 40. Europe Arginase Deficiency Drugs Market Size by Application (2019-2024) & (US$ Million)
    Table 41. Europe Arginase Deficiency Drugs Market Size by Application (2025-2030) & (US$ Million)
    Table 42. Europe Arginase Deficiency Drugs Growth Rate (CAGR) by Country (US$ Million): 2019 VS 2023 VS 2030
    Table 43. Europe Arginase Deficiency Drugs Market Size by Country (2019-2024) & (US$ Million)
    Table 44. Europe Arginase Deficiency Drugs Market Size by Country (2025-2030) & (US$ Million)
    Table 45. China Arginase Deficiency Drugs Market Size by Type (2019-2024) & (US$ Million)
    Table 46. China Arginase Deficiency Drugs Market Size by Type (2025-2030) & (US$ Million)
    Table 47. China Arginase Deficiency Drugs Market Size by Application (2019-2024) & (US$ Million)
    Table 48. China Arginase Deficiency Drugs Market Size by Application (2025-2030) & (US$ Million)
    Table 49. Asia Arginase Deficiency Drugs Market Size by Type (2019-2024) & (US$ Million)
    Table 50. Asia Arginase Deficiency Drugs Market Size by Type (2025-2030) & (US$ Million)
    Table 51. Asia Arginase Deficiency Drugs Market Size by Application (2019-2024) & (US$ Million)
    Table 52. Asia Arginase Deficiency Drugs Market Size by Application (2025-2030) & (US$ Million)
    Table 53. Asia Arginase Deficiency Drugs Growth Rate (CAGR) by Region (US$ Million): 2019 VS 2023 VS 2030
    Table 54. Asia Arginase Deficiency Drugs Market Size by Region (2019-2024) & (US$ Million)
    Table 55. Asia Arginase Deficiency Drugs Market Size by Region (2025-2030) & (US$ Million)
    Table 56. Middle East, Africa, and Latin America Arginase Deficiency Drugs Market Size by Type (2019-2024) & (US$ Million)
    Table 57. Middle East, Africa, and Latin America Arginase Deficiency Drugs Market Size by Type (2025-2030) & (US$ Million)
    Table 58. Middle East, Africa, and Latin America Arginase Deficiency Drugs Market Size by Application (2019-2024) & (US$ Million)
    Table 59. Middle East, Africa, and Latin America Arginase Deficiency Drugs Market Size by Application (2025-2030) & (US$ Million)
    Table 60. Middle East, Africa, and Latin America Arginase Deficiency Drugs Growth Rate (CAGR) by Country (US$ Million): 2019 VS 2023 VS 2030
    Table 61. Middle East, Africa, and Latin America Arginase Deficiency Drugs Market Size by Country (2019-2024) & (US$ Million)
    Table 62. Middle East, Africa, and Latin America Arginase Deficiency Drugs Market Size by Country (2025-2030) & (US$ Million)
    Table 63. Helsinn Healthcare Company Details
    Table 64. Helsinn Healthcare Business Overview
    Table 65. Helsinn Healthcare Arginase Deficiency Drugs Product
    Table 66. Helsinn Healthcare Revenue in Arginase Deficiency Drugs Business (2019-2024) & (US$ Million)
    Table 67. Helsinn Healthcare Recent Developments
    Table 68. Novartis Pharmaceuticals Company Details
    Table 69. Novartis Pharmaceuticals Business Overview
    Table 70. Novartis Pharmaceuticals Arginase Deficiency Drugs Product
    Table 71. Novartis Pharmaceuticals Revenue in Arginase Deficiency Drugs Business (2019-2024) & (US$ Million)
    Table 72. Novartis Pharmaceuticals Recent Developments
    Table 73. Horizo​​n Pharma Company Details
    Table 74. Horizo​​n Pharma Business Overview
    Table 75. Horizo​​n Pharma Arginase Deficiency Drugs Product
    Table 76. Horizo​​n Pharma Revenue in Arginase Deficiency Drugs Business (2019-2024) & (US$ Million)
    Table 77. Horizo​​n Pharma Recent Developments
    Table 78. Medicis Pharmaceutical Company Details
    Table 79. Medicis Pharmaceutical Business Overview
    Table 80. Medicis Pharmaceutical Arginase Deficiency Drugs Product
    Table 81. Medicis Pharmaceutical Revenue in Arginase Deficiency Drugs Business (2019-2024) & (US$ Million)
    Table 82. Medicis Pharmaceutical Recent Developments
    Table 83. Research Programs/Design for This Report
    Table 84. Key Data Information from Secondary Sources
    Table 85. Key Data Information from Primary Sources
List of Figures
    Figure 1. Global Arginase Deficiency Drugs Market Size Growth Rate by Type, 2019 VS 2023 VS 2030 (US$ Million)
    Figure 2. Global Arginase Deficiency Drugs Market Share by Type: 2023 VS 2030
    Figure 3. Oral Features
    Figure 4. Injection Features
    Figure 5. Global Arginase Deficiency Drugs Market Size Growth Rate by Application, 2019 VS 2023 VS 2030 (US$ Million)
    Figure 6. Global Arginase Deficiency Drugs Market Share by Application: 2023 VS 2030
    Figure 7. Hospital Case Studies
    Figure 8. Drugs Stores Case Studies
    Figure 9. Other Case Studies
    Figure 10. Arginase Deficiency Drugs Report Years Considered
    Figure 11. Global Arginase Deficiency Drugs Market Size (US$ Million), Year-over-Year: 2019-2030
    Figure 12. Global Arginase Deficiency Drugs Market Size, (US$ Million), 2019 VS 2023 VS 2030
    Figure 13. Global Arginase Deficiency Drugs Market Share by Region: 2023 VS 2030
    Figure 14. Global Arginase Deficiency Drugs Market Share by Players in 2023
    Figure 15. Global Top Arginase Deficiency Drugs Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Arginase Deficiency Drugs as of 2023)
    Figure 16. The Top 10 and 5 Players Market Share by Arginase Deficiency Drugs Revenue in 2023
    Figure 17. North America Arginase Deficiency Drugs Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 18. North America Arginase Deficiency Drugs Market Share by Type (2019-2030)
    Figure 19. North America Arginase Deficiency Drugs Market Share by Application (2019-2030)
    Figure 20. North America Arginase Deficiency Drugs Market Share by Country (2019-2030)
    Figure 21. United States Arginase Deficiency Drugs Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 22. Canada Arginase Deficiency Drugs Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 23. Europe Arginase Deficiency Drugs Market Size YoY (2019-2030) & (US$ Million)
    Figure 24. Europe Arginase Deficiency Drugs Market Share by Type (2019-2030)
    Figure 25. Europe Arginase Deficiency Drugs Market Share by Application (2019-2030)
    Figure 26. Europe Arginase Deficiency Drugs Market Share by Country (2019-2030)
    Figure 27. Germany Arginase Deficiency Drugs Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 28. France Arginase Deficiency Drugs Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 29. U.K. Arginase Deficiency Drugs Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 30. Italy Arginase Deficiency Drugs Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 31. Russia Arginase Deficiency Drugs Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 32. Nordic Countries Arginase Deficiency Drugs Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 33. China Arginase Deficiency Drugs Market Size YoY (2019-2030) & (US$ Million)
    Figure 34. China Arginase Deficiency Drugs Market Share by Type (2019-2030)
    Figure 35. China Arginase Deficiency Drugs Market Share by Application (2019-2030)
    Figure 36. Asia Arginase Deficiency Drugs Market Size YoY (2019-2030) & (US$ Million)
    Figure 37. Asia Arginase Deficiency Drugs Market Share by Type (2019-2030)
    Figure 38. Asia Arginase Deficiency Drugs Market Share by Application (2019-2030)
    Figure 39. Asia Arginase Deficiency Drugs Market Share by Region (2019-2030)
    Figure 40. Japan Arginase Deficiency Drugs Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 41. South Korea Arginase Deficiency Drugs Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 42. China Taiwan Arginase Deficiency Drugs Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 43. Southeast Asia Arginase Deficiency Drugs Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 44. India Arginase Deficiency Drugs Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 45. Australia Arginase Deficiency Drugs Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 46. Middle East, Africa, and Latin America Arginase Deficiency Drugs Market Size YoY (2019-2030) & (US$ Million)
    Figure 47. Middle East, Africa, and Latin America Arginase Deficiency Drugs Market Share by Type (2019-2030)
    Figure 48. Middle East, Africa, and Latin America Arginase Deficiency Drugs Market Share by Application (2019-2030)
    Figure 49. Middle East, Africa, and Latin America Arginase Deficiency Drugs Market Share by Country (2019-2030)
    Figure 50. Brazil Arginase Deficiency Drugs Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 51. Mexico Arginase Deficiency Drugs Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 52. Turkey Arginase Deficiency Drugs Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 53. Saudi Arabia Arginase Deficiency Drugs Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 54. Israel Arginase Deficiency Drugs Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 55. GCC Countries Arginase Deficiency Drugs Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 56. Helsinn Healthcare Revenue Growth Rate in Arginase Deficiency Drugs Business (2019-2024)
    Figure 57. Novartis Pharmaceuticals Revenue Growth Rate in Arginase Deficiency Drugs Business (2019-2024)
    Figure 58. Horizo​​n Pharma Revenue Growth Rate in Arginase Deficiency Drugs Business (2019-2024)
    Figure 59. Medicis Pharmaceutical Revenue Growth Rate in Arginase Deficiency Drugs Business (2019-2024)
    Figure 60. Bottom-up and Top-down Approaches for This Report
    Figure 61. Data Triangulation
    Figure 62. Key Executives Interviewed
SELECT A FORMAT
Added to Cart
Electronic (PDF)

$4900

This license allows only one user to access the PDF.
Electronic (PDF)

$7350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together
Electronic (PDF)

$9800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report
Add to Cart
Buy Now (15% Discount)
INQUIRE FOR DISCOUNT

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

Nano Dimension

SIMILAR REPORTS

Global Arginase Deficiency Treatment Market Insights Forecast to 2030
Global Arginase Deficiency Therapeutics Market Insights Forecast to 2030
Global Argininemia Drugs Market Insights Forecast to 2030
Global Argininemia Treatment Market Insights Forecast to 2030
Ornithine Transcarbamylase Deficiency Treatment Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Drugs to Treat Urea Cycle Disorders Market Research Report 2024
Global Hyperammonemia Medication Market Research Report 2024
Urea Cycle Disorders UCD Treatment Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Ornithine Transcarbamylase Deficiency Market Research Report 2025
Global Urea Cycle Disorder UCD Drugs Market Research Report 2024
Global Acute Hyperammonemia Treatment Drugs Market Research Report 2024
Adenosine Deaminase Deficiency Drugs Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Iron Deficiency Anemia Drug Market Insights Forecast to 2030
Global N Acetylglutamate Synthetase Deficiency NAGSD Market Research Report 2024
Global Arginase Assay Kit Market Research Report 2025
Global Anemia Treatment Drugs Market Insights Forecast to 2030
Global Arginine Amino Acid Market Research Report 2024
Adenosine Deaminase Deficiency Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Adenosine Deaminase Deficiency Treatment Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Arginase 1 Antibody Market Research Report 2024
Call
Buy Now
REQUEST FREE SAMPLE REPORT
Support Contacts
U.S. (TOLL FREE)
+1 (425) 388-2538
THE COMPANY
OUR PRODUCTS
CUSTOMER SUPPORT
POLICES
THE COMPANY
CUSTOMER SUPPORT
OUR PRODUCTS
POLICES
Copyright © 2018 Valuates.com. All Rights Reserved.
Sitemap - Privacy Policy - Terms & Conditions